BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAK7 Class: NOTE 1.250% 5/1

PALISADE CAPITAL MANAGEMENT, LP's Holding History (CIK: 0001009006)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 3,623,000 Value ($000) $3,481 Avg Close — Range —
Q3 2025
Shares 3,700,000 Value ($000) $3,511 Avg Close — Range —
Q2 2025
Shares 923,000 Value ($000) $869 Avg Close — Range —
Q1 2025
Shares 923,000 Value ($000) $873 Avg Close — Range —
Q4 2024
Shares 2,423,000 Value ($000) $2,251 Avg Close — Range —
Q3 2024
Shares 2,423,000 Value ($000) $2,305 Avg Close — Range —
Q2 2024
Shares 1,923,000 Value ($000) $1,844 Avg Close — Range —
Q1 2024
Shares 1,923,000 Value ($000) $1,909 Avg Close — Range —
Q4 2023
Shares 1,923,000 Value ($000) $1,977 Avg Close — Range —
Q3 2023
Shares 1,923,000 Value ($000) $1,909 Avg Close — Range —
Q2 2023
Shares 1,923,000 Value ($000) $1,940 Avg Close — Range —
Q1 2023
Shares 3,143,000 Value ($000) $3,271 Avg Close — Range —
Q4 2022
Shares 3,143,000 Value ($000) $3,387 Avg Close — Range —
Q3 2022
Shares 3,143,000 Value ($000) $3,139 Avg Close — Range —
Q2 2022
Shares 3,143,000 Value ($000) $3,141 Avg Close — Range —
Q1 2022
Shares 3,143,000 Value ($000) $3,168 Avg Close — Range —
Q4 2021
Shares 2,183,000 Value ($000) $2,277 Avg Close — Range —
Q3 2021
Shares 2,114,000 Value ($000) $2,108 Avg Close — Range —
Q2 2021
Shares 2,429,000 Value ($000) $2,442 Avg Close — Range —